GT Biopharma, Inc. (GTBP) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

-$28.4M

Total Assets (FY2025)

$8.1M

Total Equity (FY2025)

$5.8M

Cash Flows from Operating Activities (FY2025)

-$12.9M

Source: GT Biopharma, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.